Department of Bariatric Surgery, Orlando Regional Medical Center, Bariatric and Laparoscopy Center, Orlando Health, 89 Copeland Ave, 1st Floor, Orlando, FL 32806, USA.
Obes Surg. 2013 Feb;23(2):216-21. doi: 10.1007/s11695-012-0835-5.
Laparoscopic Roux-en-Y gastric bypass (RYGB) is an effective treatment for morbid obesity. Current average length of hospital stay (LOS) after RYGB is 2-3 days and 30-day readmission rate is 8-13 %. The aim of our study is to evaluate the effect of routine gastrostomy tube placement in perioperative outcomes of RYGB patients.
Between January 2008 and December 2010, a total of 840 patients underwent RYGB at our institution. All RYGB patients had gastrostomy tube placed, which was kept for 6 weeks. A retrospective review of a prospectively collected database was performed for all RYGB patients, noting the outcomes and complications of the procedure.
Average LOS in our patient population was 1.1 days (range, 1-14 days), and 824 (98.3 %) patients were discharged on postoperative day 1. Readmissions within 30 days after the index RYGB was observed in 31 (3.7 %) patients. Reasons included abdominal pain (n = 14), nausea/vomiting (n = 6), gastrostomy tube-related complications (n = 5), chest pain (n = 3), allergic reaction (n = 1), urinary tract infection (n = 1), and dehydration (n = 1). Of these readmitted patients, nine (1.1 %) patients required reoperations due to small bowel obstruction (n = 5), perforated anastomotic ulcer (n = 1), anastomotic leak (n = 1), subphrenic abscess (n = 1), and appendicitis (n = 1).
Routine gastrostomy tube placement in the gastric remnant at the time of RYGB seems to have contributed to our short LOS and low 30-day readmission rate.
腹腔镜 Roux-en-Y 胃旁路术(RYGB)是治疗病态肥胖的有效方法。目前 RYGB 术后平均住院时间(LOS)为 2-3 天,30 天再入院率为 8-13%。我们的研究目的是评估 RYGB 患者围手术期常规胃造口管放置对手术结果的影响。
2008 年 1 月至 2010 年 12 月,我院共对 840 例患者进行了 RYGB。所有 RYGB 患者均放置胃造口管,保留 6 周。对所有 RYGB 患者进行前瞻性收集数据库的回顾性分析,记录手术结果和并发症。
本患者人群的平均 LOS 为 1.1 天(范围 1-14 天),824 例(98.3%)患者在术后第 1 天出院。在 RYGB 指数后 30 天内观察到 31 例(3.7%)患者再入院。原因包括腹痛(n=14)、恶心/呕吐(n=6)、胃造口管相关并发症(n=5)、胸痛(n=3)、过敏反应(n=1)、尿路感染(n=1)和脱水(n=1)。这些再入院患者中,有 9 例(1.1%)患者因小肠梗阻(n=5)、吻合口溃疡穿孔(n=1)、吻合口漏(n=1)、膈下脓肿(n=1)和阑尾炎(n=1)需要再次手术。
RYGB 时在残胃中常规放置胃造口管似乎有助于缩短 LOS 和降低 30 天再入院率。